Prelude Therapeutics Incorporated

Industry

  • Pharmaceuticals
    • Vaccines
    • Specialty Pharmaceuticals
  • Biotechnology
    • Drug Discovery Technologies
See more in Biomedtracker

Latest on Prelude Therapeutics Incorporated

Scrip

What To Look Out For At ESMO 2024

 
• By Alexandra Shimmings

Among the presentations at the European Society for Medical Oncology meeting in Barcelona, Spain will be data for older immune checkpoint inhibitors from Merck & Co., Inc. , AstraZeneca PLC and Br

Scrip

Deal Watch: Lilly Turns To Oblique For Antibody Discovery

 
• By Joseph Haas

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Lilly Teams With Oblique On Antibody Di

Scrip

Sellas Teases Biomarker-Driven Efficacy Of AML Drug With Phase IIa Results

 
• By Alaric DeArment

SELLAS Life Sciences Group, Inc. is in a strong position in acute myeloid leukemia (AML) with positive data from a Phase IIa study of SLS009 and the completion of enrollment in its Phase III trial of

Scrip

Deal Watch: Biogen, AbCellera Team To Find Novel Way To Cross Blood-Brain Barrier

 
• By Joseph Haas and Lisa Takagi

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Biogen’s Pact With AbCellera Will Focus